ISIS-PTP1BRx: Phase I data

Top-line data from a double-blind Phase I trial in 29 obese patients showed that 400 mg ISIS-PTP1BRx significantly increased mean high-molecular weight adiponectin (ADIPOQ) levels from baseline to da...